Norocillin LA Injection

Presentation:
Norocillin LA is a sterile white aqueous suspension. Each ml contains:

Benzathine Penicillin 112.5 mg
Procaine Penicillin. 150.0 mg
Methyl Hydroxybenzoate 0.200 % w/v
Propyl Hydroxybenzoate 0.020 % w/v
as antimicrobial preservatives.

Uses:
Norocillin LA is indicated in the treatment of systemic infections caused by or associated with organisms sensitive to penicillin in Horses, Dogs and Cats.

Procaine Penicillin when administered by intramuscular injection will provide effective therapeutic blood levels for approximately 24 hours, whilst benzathine penicillin is absorbed slowly in the tissue fluid and maintains blood levels for three to four days.

Norocillin LA is of particular value in reducing the number of injections in a course of penicillin therapy.

Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information.

Dosage & Administration:
By deep intramuscular injection only. This product is recommended for a single administration only.

Horses: 6 mg/kg bodyweight procaine penicillin with 4.5 mg/kg bodyweight benzathine penicillin equivalent to 1 ml per 25 kg bodyweight.

Dogs and Cats: 15 mg/kg procaine penicillin with 11.25 mg/kg benzathine penicillin equivalent to 1 ml per 10 kg bodyweight.

Withdrawal Period:
Not to be used in horses intended for human consumption.

Treated horses may never be slaughtered for human consumption.

The horse must have been declared as not intended for human consumption under national horse passport legislation.

Contraindictions, Warnings etc:
Contraindicated in known cases of hypersensitivity to penicillins.

Do not inject intravenously.

Care should be taken not to overdose.

Not to be used on very small herbivores such as guinea pigs, gerbils and hamsters.

Not effective against beta-lactamase producing organisms.

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact.

Hypersensitivity to penicillin may lead to cross reactions to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.

1. Do not handle this product if you know you are sensitised, or if you have been advised not to work with such preparations.
2. Handle this type of product with great care to avoid exposure, taking all recommended precautions.
3. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty with breathing are moreserious symptoms and require urgent medical attention.

Pharmaceutical Precautions:
Store below 25ÂșC.

Protect from light.

Following withdrawal of the first dose, use the product within 28 days. Discard unused material.

When the container is broached (opened) for the first time, using the in-use shelf-life which is specified on this package leaflet, the date on which any product remaining in the container should be worked out. This discard date should be written in the space provided on the label.

Keep the container in outer carton.

Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority